Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease
暂无分享,去创建一个
Laura Beretta | George N. Ioannou | Jorge A. Marrero | J. Marrero | L. Beretta | G. Ioannou | A. Ruggieri | S. Cermelli | Silvia Cermelli | Anna Ruggieri
[1] Chris Sander,et al. Cellular cofactors affecting hepatitis C virus infection and replication , 2007, Proceedings of the National Academy of Sciences.
[2] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[3] N. Chalasani,et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis , 2011, Hepatology.
[4] Y. Maehara,et al. Clinical significance and potential of hepatic microRNA‐122 expression in hepatitis C , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[5] E. Boyko,et al. The Prevalence and Predictors of Elevated Serum Aminotransferase Activity in the United States in 1999–2002 , 2006, The American Journal of Gastroenterology.
[6] S. Lowe,et al. miR-221 overexpression contributes to liver tumorigenesis , 2009, Proceedings of the National Academy of Sciences.
[7] Ivan Rusyn,et al. Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice , 2010, Laboratory Investigation.
[8] H. Hermeking. p53 enters the microRNA world. , 2007, Cancer cell.
[9] C. Croce,et al. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives , 2010, Cell Death and Differentiation.
[10] Hiroshi Yoshida,et al. Sequencing and Bioinformatics-Based Analyses of the microRNA Transcriptome in Hepatitis B–Related Hepatocellular Carcinoma , 2011, PloS one.
[11] Michael Niepmann,et al. microRNA-122 stimulates translation of hepatitis C virus RNA , 2008, The EMBO journal.
[12] Peter Schirmacher,et al. MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma , 2007, Hepatology.
[13] K. Batts,et al. Chronic hepatitis. An update on terminology and reporting. , 1995, The American journal of surgical pathology.
[14] L. Hood,et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury , 2009, Proceedings of the National Academy of Sciences.
[15] Yue Wang,et al. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. , 2010, Clinical chemistry.
[16] N. Rajewsky,et al. Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.
[17] H. Conjeevaram,et al. Serum lipids and their associations with viral levels and liver disease severity in a treatment‐naïve chronic hepatitis C type 1‐infected cohort , 2011, Journal of viral hepatitis.
[18] Hui Zhou,et al. Liver‐enriched transcription factors regulate MicroRNA‐122 that targets CUTL1 during liver development , 2010, Hepatology.
[19] Andrew P Lewis,et al. Regulation and biological function of the liver-specific miR-122. , 2010, Biochemical Society transactions.
[20] B. McMahon,et al. Chronic hepatitis B , 2001, Hepatology.
[21] W. Tan,et al. Circulating MicroRNAs, miR‐21, miR‐122, and miR‐223, in patients with hepatocellular carcinoma or chronic hepatitis , 2011, Molecular Carcinogenesis.
[22] W. Filipowicz,et al. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy , 2009, Nature Medicine.
[23] Mark Graham,et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. , 2006, Cell metabolism.
[24] W. Filipowicz,et al. The liver-specific microRNA miR-122: biology and therapeutic potential. , 2011, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.
[25] Holger Sültmann,et al. Serum microRNAs as non-invasive biomarkers for cancer , 2010, Molecular Cancer.
[26] C. Croce,et al. Targeting microRNAs in cancer: rationale, strategies and challenges , 2010, Nature Reviews Drug Discovery.
[27] A. Sanyal. Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[28] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[29] S. Lowe,et al. 579 MIR-221 OVEREXPRESSION CONTRIBUTES TO LIVER TUMORIGENESIS , 2010 .
[30] Anton P McCaffrey,et al. Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans , 2010, Laboratory Investigation.
[31] Eva Herrmann,et al. Serum miR-122 as a Biomarker of Necroinflammation in Patients With Chronic Hepatitis C Virus Infection , 2011, The American Journal of Gastroenterology.
[32] S. Lemon,et al. Regulation of Hepatitis C Virus Translation and Infectious Virus Production by the MicroRNA miR-122 , 2010, Journal of Virology.
[33] Shi‐Mei Zhuang,et al. A novel GSK‐3 beta–C/EBP alpha–miR‐122–insulin‐like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma , 2010, Hepatology.
[34] S. Thorgeirsson,et al. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties , 2009, Oncogene.
[35] L. Beretta,et al. The heat shock cognate protein 70 is associated with hepatitis C virus particles and modulates virus infectivity , 2009, Hepatology.
[36] E. Kroh,et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.
[37] Takahiro Ochiya,et al. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis , 2010, Cancer science.
[38] M. Albitar,et al. Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma , 2011, Journal of clinical gastroenterology.
[39] F. Negro,et al. Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data , 2009, Liver international : official journal of the International Association for the Study of the Liver.